HCM Q1 2023 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$266M+163.7% YoY

Gross Profit

$162M60.9% margin

Operating Income

$56M21.0% margin

Net Income

$84M31.6% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

+137.5%

Cash Flow

Operating Cash Flow

$113M

Free Cash Flow

$101M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$497M

Stockholders' Equity

$782M

Cash & Equivalents

$223M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$266M	$101M	+163.7%
Gross Profit	$162M	-$59M	+377.4%
Operating Income	$56M	-$98M	+156.7%
Net Income	$84M	-$81M	+203.5%